EMvision Medical Devices Ltd.ASX: EMV

Emu Pivotal Validation Trial Commences

· Issued by EMvision Medical Devices Ltd.

Filed with ASX · · 5 pages · English

Summary by 6ix AI

EMVision Medical Devices Ltd. has announced the commencement of the EMU Pivotal Validation Trial for its emu™ bedside brain scanner, aimed at supporting FDA clearance. The trial will take place at multiple sites, including The Royal Melbourne Hospital in Australia and the University of Texas Health Science Center in the US.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

EMvision Medical Devices Ltd. on 6ix

Story so far

Earlier from EMvision Medical Devices

Later from EMvision Medical Devices

All EMvision Medical Devices news releases